Suitability of DCE-MRI for Detection of Vascular Changes After VBT

Completed · Not applicable

Conditions studied: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus

In brief

This is a pilot study of DCE MR imaging to detect vascular changes in the vagina during and after radiotherapy n patients receiving adjuvant brachytherapyfor cervical or endometrial cancer.

Key facts

Study ID

NCT01991808

Run by

Abramson Cancer Center at Penn Medicine

People needed

16

Starts

2013-10-01

Expected to finish

2016-12-08

Last updated by the study team

2019-11-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Must be 18 years of age.
• Must have histologically confirmed carcinoma of the cervix, carcinoma or carcinosarcoma of the uterus.
• Subjects are receiving intracavitary brachytherapy.
• ECOG performance status of 0-2.
• Creatinine clearance 30.

You may not qualify if…

• Subjects with an inability to tolerate MR imaging (i.e. claustrphobia)
• Study subjects who have contraindication to MRI scanning such as but not limited to subjects with pacemakers, metal fragments in the eye or certain metallic implants.
• Patients who do not speak or read English.

Where it is running

• Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.